SEC Form 4 · accession 0001177648-17-000020
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lesley Russell
Director
Period of report
Feb 16, 2017
Accepted (ET)
Feb 21, 2017 · 7:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $29.02 | Feb 16, 2017 | A | 2,500 | A | — | Nov 18, 2026 | Common Stock | 2,500 | 2,500 | D |
Explanation of responses
- F1Such option became and will become exercisable monthly in substantially equal installments over three years, beginning from November 18, 2016.